As Lyrica patent expiry looms, Pfizer buys Array for $11.4bnPfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at Share XAs Lyrica patent expiry looms, Pfizer buys Array for $11.4bnhttps://pharmaphorum.com/news/as-lyrica-patent-expiry-looms-pfizer-buys-array-for-11-4bn/
Does NEMO bring us a step closer in the fight against melanoma?Options for treatment in metastatic melanoma have increased significantly in terms of efficacy and reduction of mortality in Share XDoes NEMO bring us a step closer in the fight against melanoma?https://pharmaphorum.com/partner-content-oncology/nemo-bring-us-step-closer-fight-melanoma/
